Catalent has patented a system for dosing pharmaceutical formulations using a density flow meter to measure density. The system includes a recirculation system and pumps to dose into molds, stopping when density falls below a set threshold. GlobalData’s report on Catalent gives a 360-degree view of the company including its patenting strategy. Buy the report here.
Smarter leaders trust GlobalData
According to GlobalData’s company profile on Catalent, was a key innovation area identified from patents. Catalent's grant share as of May 2024 was 44%. Grant share is based on the ratio of number of grants to total number of patents.
System for dosing pharmaceutical formulation based on density measurement
A recently granted patent (Publication Number: US12005029B2) discloses a system and method for dosing a pharmaceutical formulation. The system includes a recirculation system with a density flow meter to measure the density of the formulation. It also features at least one pump connected to the recirculation system, which displaces the formulation into preformed molds and stops when the density measured by the flow meter falls below a predetermined threshold. Additionally, a computer is integrated into the system, communicating with the density flow meter and pump to control dosing based on density data.
The method outlined in the patent involves measuring the density of the pharmaceutical formulation, dosing it into molds, and halting dosing when the density falls below a set threshold. A density flow meter sends density data to a computer, which then sends instructions to the pump to stop dosing. The formulation may contain surfactants like sodium lauryl sulfate or sodium docusate. This innovative system and method ensure precise dosing of pharmaceutical formulations, enhancing accuracy and efficiency in the manufacturing process.
To know more about GlobalData’s detailed insights on Catalent, buy the report here.
Data Insights
From
The gold standard of business intelligence.
Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.
GlobalData, the leading provider of industry intelligence, provided the underlying data, research, and analysis used to produce this article.
GlobalData Patent Analytics tracks bibliographic data, legal events data, point in time patent ownerships, and backward and forward citations from global patenting offices. Textual analysis and official patent classifications are used to group patents into key thematic areas and link them to specific companies
